Skip to main content
. 2023 Jan 10;11(1):E24–E32. doi: 10.9778/cmajo.20210284

Figure 1:

Figure 1:

Comparison of key drivers of uncertainty (model inputs) for % change in cost per disability-adjusted life year (DALY) averted for scenario 1 (base) to scenario 5 (vaccines at 2, 4 and 6 mo as a part of the hexavalent approach to adolescent vaccination). Note: HBeAg = hepatitis B e antigen, HBsAg = hepatitis B surface antigen, HBV = hepatitis B virus, WoCBA = women of child-bearing age.